Biotech · Private company
Ra Pharmaceuticals
Track this companyFree. Adds Ra Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- zilucoplan (RA101495)Phase 3 · Myasthenia Gravis, GeneralizedClinicalTrials.gov · fetched Nov 12, 2026
- zilucoplanPhase 2 · Immune Mediated Necrotizing MyopathyClinicalTrials.gov · fetched Nov 12, 2026
- zilucoplan (RA101495)Phase 2 · Generalized Myasthenia GravisClinicalTrials.gov · fetched Nov 12, 2026
- Zilucoplan (RA101495)Phase 2 · Paroxysmal Nocturnal Hemoglobinuria (PNH)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- HEALEY ALS Platform Trial - Regimen A ZilucoplanPHASE2_PHASE3 · COMPLETED · started Jul 29, 2020ClinicalTrials.gov NCT04436497 · fetched Nov 12, 2026
- Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing MyopathyPHASE2 · TERMINATED · started Nov 7, 2019ClinicalTrials.gov NCT04025632 · fetched Nov 12, 2026
- Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia GravisPHASE3 · COMPLETED · started Sep 17, 2019ClinicalTrials.gov NCT04115293 · fetched Nov 12, 2026
- Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia GravisPHASE2 · COMPLETED · started Oct 11, 2017ClinicalTrials.gov NCT03315130 · fetched Nov 12, 2026
- Extension Study of RA101495 for Patients With PNH Who Have Completed a Zilucoplan (RA101495) Clinical StudyPHASE2 · TERMINATED · started Jul 17, 2017ClinicalTrials.gov NCT03225287 · fetched Nov 12, 2026
- Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to EculizumabPHASE2 · COMPLETED · started Apr 17, 2017ClinicalTrials.gov NCT03030183 · fetched Nov 12, 2026